X4 Pharmaceuticals Inc (NASDAQ: XFOR) kicked off on Monday, up 13.89% from the previous trading day, before settling in for the closing price of $3.6. Over the past 52 weeks, XFOR has traded in a range of $1.35-$26.83.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 47.41%. While this was happening, its average annual earnings per share was recorded 63.60%. With a float of $78.31 million, this company’s outstanding shares have now reached $87.44 million.
X4 Pharmaceuticals Inc (XFOR) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of X4 Pharmaceuticals Inc is 10.44%, while institutional ownership is 32.31%. The most recent insider transaction that took place on Oct 23 ’25, was worth 249,997. In this transaction Executive Chairman of this company bought 86,206 shares at a rate of $2.90, taking the stock ownership to the 376,087 shares. Before that another transaction happened on May 16 ’25, when Company’s Chief Commercial Officer bought 1,032 for $2.48, making the entire transaction worth $2,561. This insider now owns 25,337 shares in total.
X4 Pharmaceuticals Inc (XFOR) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -6 earnings per share (EPS), lower than consensus estimate (set at -4.72) by -1.28. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.24 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 63.60% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 48.40% during the next five years compared to 47.41% growth over the previous five years of trading.
X4 Pharmaceuticals Inc (NASDAQ: XFOR) Trading Performance Indicators
Take a look at X4 Pharmaceuticals Inc’s (XFOR) current performance indicators. Last quarter, stock had a quick ratio of 5.48. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.55.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -10.01, a number that is poised to hit -0.26 in the next quarter and is forecasted to reach -0.92 in one year’s time.
Technical Analysis of X4 Pharmaceuticals Inc (XFOR)
The latest stats from [X4 Pharmaceuticals Inc, XFOR] show that its last 5-days average volume of 1.61 million was superior to 1.41 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 44.84%.
During the past 100 days, X4 Pharmaceuticals Inc’s (XFOR) raw stochastic average was set at 79.02%, which indicates a significant decrease from 90.15% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.32 in the past 14 days, which was lower than the 0.34 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.60, while its 200-day Moving Average is $3.84. Now, the first resistance to watch is $4.34. This is followed by the second major resistance level at $4.57. The third major resistance level sits at $4.93. If the price goes on to break the first support level at $3.74, it is likely to go to the next support level at $3.38. The third support level lies at $3.15 if the price breaches the second support level.
X4 Pharmaceuticals Inc (NASDAQ: XFOR) Key Stats
The company with the Market Capitalisation of 358.49 million has total of 87,437K Shares Outstanding. Its annual sales at the moment are 2,560 K in contrast with the sum of -37,450 K annual income. Company’s last quarter sales were recorded 1,770 K and last quarter income was -29,820 K.
